It is a synthetic peptide fragment derived from the C-terminal end of human growth hormone, specifically amino acids 176 through 191
Semaglutide belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists
The Defense Department has not released an exact accounting of the number of GLP-1 prescriptions written for weight loss, but a 2024 report noted that, by late 2023, the drugs made up roughly one-third of all prescription weight-loss medications for active-duty military personnel
The current program is easier to misunderstand than a single all-inclusive price because the membership and medication renew separately
It increases the risk of: Type 2 diabetes MASLD (metabolic dysfunction-associated steatotic liver disease, formerly called NAFLD) Cardiovascular disease The loss of estrogen also accelerates sarcopenia, the loss of lean muscle mass, which further slows metabolism and reduces energy expenditure
Its designed for GLP-1 users but beneficial for anyone needing clean, plant-based protein and digestive support